基于医疗设备的神经调节用于帕金森病的运动症状:系统性审查和元分析
Paulo E P Teixeira1, João Victor Ribeiro2,3, João Pedro Serrao Perin2,3
1Highland Instruments, Cambridge, MA, United States.
Frontiers in neurology
|March 2, 2026
概括
基于医疗设备的神经调节 (MDBN) 在帕金森病 (PD) 中提供了适度的运动症状改善. 研究结果表明,分析策略和对比剂选择显著影响临床试验中观察到的效果大小.
科学领域:
- 神经学 神经学
- 生物医学工程 生物医学工程
- 临床试验 临床试验
背景情况:
- 帕金森病 (PD) 的运动症状是基于设备的神经调节 (MDBN) 的疗法,如深度大脑刺激 (DBS),跨磁刺激 (TMS) 和跨直流刺激 (tDCS) 的目标.
- 据报道,这些MDBN技术的有效性在不同研究中存在很大差异.
研究的目的:
- 综合来自随机临床试验 (RCT) 的证据,比较各种MDBN技术改善帕金森病运动症状的疗效.
- 调查导致PDMDBN试验报告的效果大小变化的因素.
主要方法:
- 按照PRISMA指南进行了系统审查和随机效应元分析.
- 从主要数据库 (MEDLINE,Embase,Web of Science) 中确定了评估PD运动功能的MDBN (通过UPDRS3测量) 的RCT.
- 使用元回归来探索方法,人口和干预变量对效果大小的影响.
主要成果:
- 该元分析包括47个RCT (2,638名参与者),包括30种非侵入性 (rTMS,tDCS) 和17种侵入性 (DBS) MDBN方法.
- 活跃的MDBN在39项研究中显示出一种小但显著的运动改善 (SMD = -0.18,p = 0.008).
- 超回归显示,治疗意图分析与更大的效果相关,而假刺激作为对比剂产生了较小的效果.
结论:
- 对于患有帕金森病的人来说,MDBN技术在运动功能方面提供了适度但统计学上显著的改善.
- 方法因素,特别是分析策略和假比较器的选择,显著影响MDBN干预措施报告的效果大小.
- 这项研究在多臂试验中独特地将每个活跃臂的单独效果大小纳入了多臂试验中,从而提高了元分析的精度.
更多相关视频
07:14A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
Published on: May 31, 2016
15.5K
14:14Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
9.4K
相关概念视频
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Neural Regulation
43.8K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.8K
